Maven Securities’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-387	Closed	-$163K	–	275
2023 Q1	$163K	Buy	+387	New	+$163K	﹤0.01%	189
2021 Q4	–	Sell	-17	Closed	-$109K	–	387
2021 Q3	$109K	Buy	+17	New	+$109K	﹤0.01%	456